INTERCEPT PHARMACEUTICALS, INC.·4

Jan 5, 7:01 PM ET

Weyer Christian 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 5, 2021

Insider Transaction Report

Form 4
Period: 2020-12-31
Weyer Christian
EVP Research and Development
Transactions
  • Tax Payment

    Common Stock

    2020-12-31$24.70/sh779$19,24115,198 total
  • Tax Payment

    Common Stock

    2021-01-01$24.70/sh54$1,33415,144 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Documents

1 file
  • 4
    tm211606-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT